Breast Cancer News & Features

Healthier lifestyles might improve the prognosis of people with breast cancer if they will stick with the positive changes, researchers say.

A familiar drug for urinary incontinence has been found to reduce hot flashes in women after breast cancer.

With Same Breast Cancer Care, Black Women Do Worse By Maureen SalamonHealthDay Reporter THURSDAY, Dec. 6, 2018 (HealthDay News) -- Even with the same treatment, black women with the most common form of breast cancer experience higher recurrence and death rates than white women, a new trial reveals.The finding pokes holes in the prevailing notion that black women with breast cancer fare worse due to less access to quality medical care, experts said. While that factor may contribute to poorer outcomes, other factors -- such as the way drugs are metabolized based on race -- may be

New research shows that a lower dose of the hormone therapy Tamoxifen is as effective as the higher dose treatment in helping to prevent breast cancer from returning and guarding against new cancers in women who had high-risk breast tissue.

All of the women in the new trial had undergone a standard treatment scenario. First, they received traditional chemotherapy and the drug Herceptin (trastuzumab) -- an antibody that targets HER2-positive cancer cells. Then they had surgery to remove any remaining cancer.

People with breast cancer who took part in a breast cancer screening program had a 60 percent lower risk of dying from the disease in the 10 years after diagnosis, and a 47 percent lower risk 20 years after diagnosis, Swedish researchers report.

Compared with night owls, women who are early risers had a 40 percent lower risk of breast cancer, a new British study of the link between sleep traits and breast cancer risk found.

Researchers in two new pilot studies report that ketoprofen, a common anti-inflammatory drug, significantly eases swelling and other skin damage from lymphedema.

Women who lost 5 percent or more of their body weight had a 12 percent lower breast cancer risk than those whose weight remained the same, according to a study in the journal Cancer.

They analyzed studies that included more than 1.2 million women and found that those who regularly ate processed meats were 9 percent more likely to develop breast cancer, CNN reported.

Breast cancer survivors who have a gene linked to Alzheimer’s disease and who underwent chemotherapy were more likely to have long-term impairment in brain function, researchers say.

The researchers found that even though the women were relatively well-off, nearly 16 percent said their diagnosis was financially catastrophic. More than half had out-of-pocket costs of $3,500 or more. And 5 percent faced out-of-pocket costs of more than $30,000.

In the United States, even though black women are less likely to develop breast cancer than white women, they are 40 percent more likely to die from it, the researchers noted.

On average, breast cancer survivors get hit with an extra $1,100 in yearly out-of-pocket cancer-driven costs, researchers have found.

An experimental drug could improve survival for women with breast cancer who have the BRCA1 and BRCA2 gene mutations, a new study says.

The team also found that mutations in the BRIP1 and RAD51C genes were associated with a more moderate risk of triple-negative breast cancer.

Women who take the chemotherapy drug trastuzumab (Herceptin) for HER2-positive breast cancer can be at higher risk for heart failure and should have their hearts monitored during treatment, new research finds. The complication is not common, and in many cases, the benefits of the chemotherapy still outweigh the risks. But regular checks should be a priority.

Could More Vitamin D Help Prevent Breast Cancer? By Robert PreidtHealthDay Reporter WEDNESDAY, June 27, 2018 (HealthDay News) -- High levels of vitamin D may reduce a woman's risk of breast cancer, a new study suggests.Researchers looked at more than 5,000 women, 55 and older, and found that those with vitamin Dblood levels of 60 nanograms per milliliter (ng/mL) or more had an 80 percent lower risk for breast cancer than those with levels of 20 ng/mL or less.The researchers also found that among women with vitamin D blood levels between 20 and 60 ng/mL, the higher

Study Confirms Dense Breasts Are Prone to Cancer By Serena GordonHealthDay Reporter TUESDAY, June 26, 2018 (HealthDay News) -- Using automated breast density measurements, Norwegian researchers were able to more precisely confirm that women with dense breasts have a higher risk of breast cancer. The study included more than 100,000 women and more than 300,000 screening exams. "We found that screening examinations of women having dense breasts showed higher rates of recall and biopsy, and higher odds of screen-detected and interval breast cancers than women with non-dense breasts," said the study's senior author, Solveig Hofvind. She is

Besides demonstrating an ability to eliminate breast cancer, Rosenberg and his team already have additional preliminary results suggesting that the technique is similarly effective against both liver cancer and colon cancer.

The findings could be a game-changer in breast cancer care, researchers and experts said.

As the researchers explained, taselisib has already proven beneficial for people fighting head-and-neck cancers or certain gynecological tumors. Would it do the same for hormone-sensitive breast cancers?

Data from the Women's Health Initiative (WHI) study had already found that women who ate a low-fat diet were at lower odds of developing more aggressive forms of breast cancer.

Currently, the U.S. Preventive Services Task Force recommends that annual screenings start at age 50 for most women, while the American Cancer Society advises that annual screenings begin at age 45.

Swelling results when lymph vessels can't carry fluid away from the area, and it can lead to decreased range of movement and infection on the affected side.